ASX
Clarity Pharmaceuticals
CU6:ASX•Healthcare
Sensitive ASX Announcement
First 2 participants dosed with Cu-64 SAR-bisPSMA in Co-PSMA
Published: 26/11/24, 09:56am (AEST)•5 pages